MET is highly expressed in ~67% of primary colorectal carcinomas (Gayyed et al., 2015) and overexpression is associated with tumor progression and metastasis (Baldus et al., 2007; Luo and Xu, 2014; Zeng et al., 2004). The gene discussed is MET; the disease is neoplasm.